Albert James Hicks III, M.D.
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) in Oklahoma City, Oklahoma, trained at Temple University School of Medicine (class of 2007). Their prescriptions cost Medicare Part D more than their services did: $213,273 for 677 claims, against $89,485 paid for services in 2024. Alnylam Pharmaceuticals Inc. was the largest of 12 companies reporting payments in 2025, $217,685 in all, mostly speaking and faculty fees.
Overview
| NPI | 1386808012 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Jul 11, 2008 |
| Last updated in NPPES | Sep 2, 2026 |
| Certified by provider | Sep 2, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | 50323 | OK |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 50323 | OK |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (MD) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 152 |
|---|---|
| Services billed | 800 across 18 procedure codes |
| Paid by Medicare | $89,485 |
Part D prescriptions in 2024
| Prescriptions (claims) | 677 · 1,531 30-day fills |
|---|---|
| Patients | 69 |
| Total drug cost | $213,273 |
| Generic share | 71% of claims |
Education and affiliations
| Medical school | Temple University School of Medicine |
|---|---|
| Graduation year | 2007 |
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Cardiovascular Disease (Cardiology), Internal Medicine |
Medical group
- University of Maryland Physicians PABaltimore, MD · 404 clinicians
Hospital affiliations
- Umd Upper Chesapeake Medical CenterBel Air, MD
- University of Maryland Medical CenterBaltimore, MD
Industry payments (Open Payments)
- 2025$217,685 · 192 payments from 12 companies
- 2024$124,076 · 155 payments from 11 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | $101,137 | 71 |
| Bridgebio Pharma, Inc. | $75,581 | 59 |
| Cvrx, Inc. | $26,534 | 37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,027 | 7 |
| Lilly USA, LLC | $6,739 | 7 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$155,235 · 54 payments
- Consulting Fee$38,001 · 12 payments
- Travel and Lodging$17,945 · 45 payments
- Food and Beverage$6,504 · 81 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Oklahoma City
- 1649590134
- 1265572366
- 1982871521
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Oklahoma →